| 1 |
35453005 | Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: Adjusting prescription to patient features. | 2022 Jun |
1 |
| 2 |
35585779 | Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials. | 2022 May 18 |
1 |
| 3 |
32606658 | Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers. | 2020 |
1 |
| 4 |
32989835 | Hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) - a retrospective study. | 2020 Dec |
1 |
| 5 |
30636337 | Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization Study. | 2019 Feb |
1 |
| 6 |
30983880 | Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain. | 2019 |
3 |
| 7 |
28057325 | Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. | 2017 Feb |
1 |
| 8 |
28210513 | Seizure following the Use of the COX-2 Inhibitor Etoricoxib. | 2017 |
2 |
| 9 |
28676124 | Evaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns. | 2017 Jul 4 |
1 |
| 10 |
28778815 | Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial. | 2017 Nov |
1 |
| 11 |
28884717 | [Clinical and emotional/behavioral characteristics of acute and chronic low-back pain]. | 2017 |
2 |
| 12 |
26838881 | Poly (caprolactone) microparticles and chitosan thermogels based injectable formulation of etoricoxib for the potential treatment of osteoarthritis. | 2016 Apr 1 |
1 |
| 13 |
27007068 | Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis. | 2016 Aug |
2 |
| 14 |
27502582 | Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. | 2016 Aug 8 |
2 |
| 15 |
27576781 | Mucosal exfoliation as a selective reaction to etoricoxib. | 2016 Dec |
1 |
| 16 |
27779319 | Synthesis of New Tricyclic and Tetracyclic Fused Coumarin Sulfonate Derivatives and Their Inhibitory Effects on LPS-Induced Nitric Oxide and PGE2 Productions in RAW 264.7 Macrophages: Part 2. | 2016 Nov |
1 |
| 17 |
26904451 | Etoricoxib-induced pretibial erythema and edema. | 2015 Dec |
1 |
| 18 |
24461582 | Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma. | 2014 Aug |
1 |
| 19 |
24469906 | Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjects. | 2014 Jul |
2 |
| 20 |
25029569 | Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen. | 2014 Dec |
1 |
| 21 |
25229174 | Reversible cerebral vasoconstriction syndrome possibly induced by etoricoxib. | 2014 Sep-Oct |
1 |
| 22 |
23964558 | Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease. | 2013 |
3 |
| 23 |
24352312 | Analgesic effect of etoricoxib compared to ibuprofen on post endodontic pain. | 2013 Sep |
1 |
| 24 |
24383977 | Etoricoxib: a safe alternative for NSAID intolerance in Asian patients. | 2013 Dec |
1 |
| 25 |
21848948 | Prophylactic etoricoxib is effective in preventing "first of Ramadan" headache: a placebo-controlled double-blind and randomized trial of prophylactic etoricoxib for ritual fasting headache. | 2012 Apr |
1 |
| 26 |
22582102 | Efficacy of etoricoxib, celecoxib, lumiracoxib, non-selective NSAIDs, and acetaminophen in osteoarthritis: a mixed treatment comparison. | 2012 |
1 |
| 27 |
23265037 | Effects of preoperative single dose Etoricoxib on postoperative pain and sleep after lumbar diskectomy: prospective randomized double blind controlled study. | 2012 Jun |
1 |
| 28 |
21539467 | Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. | 2011 Apr |
1 |
| 29 |
21905970 | Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis. | 2011 Oct |
1 |
| 30 |
20363696 | Formulation and evaluation of mouth dissolving tablets of the Etoricoxib. | 2010 Apr |
2 |
| 31 |
20399943 | Pain control in first-trimester surgical abortion: a systematic review of randomized controlled trials. | 2010 May |
1 |
| 32 |
20504378 | Etoricoxib--preemptive and postoperative analgesia (EPPA) in patients with laparotomy or thoracotomy--design and protocols. | 2010 May 27 |
1 |
| 33 |
20678677 | Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan. | 2010 Jul |
2 |
| 34 |
21373319 | Etoricoxib-induced life-threatening hyperkalemia and acute kidney dysfunction against the background of telmisartan and a low sodium diet. | 2010 Aug 20 |
1 |
| 35 |
19470170 | The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study. | 2009 May 26 |
1 |
| 36 |
19589894 | Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo. | 2009 Sep |
1 |
| 37 |
19634927 | Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis. | 2009 Jul 30 |
1 |
| 38 |
18171381 | Primary stabbing headache can be responsive to etoricoxib, a selective COX-2 inhibitor. | 2008 Jan |
1 |
| 39 |
18182814 | Etoricoxib-induced erythema-multiforme-like eruption. | 2008 |
2 |
| 40 |
18434566 | Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. | 2008 Jun |
1 |
| 41 |
18564626 | Safety of etoricoxib in patients with reactions to NSAIDs. | 2008 |
1 |
| 42 |
19209280 | Risk management profile of etoricoxib: an example of personalized medicine. | 2008 Oct |
1 |
| 43 |
23100954 | Management of chronic synovitis in patients with hemophilia: with special reference to developing countries. | 2008 Dec |
1 |
| 44 |
17292766 | Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. | 2007 Feb 10 |
1 |
| 45 |
17691997 | Global gastrointestinal safety profile of etoricoxib and lumiracoxib. | 2007 |
1 |
| 46 |
17953635 | Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance. | 2007 Nov |
2 |
| 47 |
16291600 | Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy. | 2006 Mar 1 |
1 |
| 48 |
16454836 | The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. | 2006 Feb |
2 |
| 49 |
16598848 | Different COX-independent effects of the COX-2 inhibitors etoricoxib and lumiracoxib. | 2006 Apr 14 |
2 |
| 50 |
17265571 | Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib. | 2006 Dec |
2 |